New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

by Ken Kingery,Duke UniversityCredit: Unsplash/CC0 Public DomainBiomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mous
Oncology January 02,2024
Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

by Ken Kingery,Duke UniversityCredit: Unsplash/CC0 Public DomainBiomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mous
Oncology January 02,2024
Metachronous pathology assessed in young-onset colorectal cancer survivors

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published
Oncology January 02,2024
Metachronous pathology assessed in young-onset colorectal cancer survivors

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published
Oncology January 02,2024
Young cancer survivors face elevated risk of developing cardiovascular disease, but factors that may impact this risk

Young cancer survivors face elevated risk of developing cardiovascular disease, but factors that may impact this risk

byWileyCredit: Pixabay/CC0 Public DomainAdolescent and young adult (AYA) cancer survivors are at risk of experiencing treatment-related effects later in life, including damage to the heart. New
Oncology January 02,2024
Young cancer survivors face elevated risk of developing cardiovascular disease, but factors that may impact this risk

Young cancer survivors face elevated risk of developing cardiovascular disease, but factors that may impact this risk

byWileyCredit: Pixabay/CC0 Public DomainAdolescent and young adult (AYA) cancer survivors are at risk of experiencing treatment-related effects later in life, including damage to the heart. New
Oncology January 02,2024
Age, cancer type affect COVID-19 vaccine uptake in cancer patients

Age, cancer type affect COVID-19 vaccine uptake in cancer patients

by Elana GotkineFor patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 inCance
Oncology January 02,2024
Age, cancer type affect COVID-19 vaccine uptake in cancer patients

Age, cancer type affect COVID-19 vaccine uptake in cancer patients

by Elana GotkineFor patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 inCance
Oncology January 02,2024
What do you know about these three rare childhood cancers?

What do you know about these three rare childhood cancers?

by Laurel KellyCredit: Unsplash/CC0 Public DomainChildhood cancer rates have been rising slightly for the past few decades, and about 10,470 children in the U.S. under the age of 15 will be diagnosed
Oncology January 02,2024
What do you know about these three rare childhood cancers?

What do you know about these three rare childhood cancers?

by Laurel KellyCredit: Unsplash/CC0 Public DomainChildhood cancer rates have been rising slightly for the past few decades, and about 10,470 children in the U.S. under the age of 15 will be diagnosed
Oncology January 02,2024
Role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies

Role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies

by Impact Journals LLCThe effect of pyrethroid derivatives on induction of autophagy. Credit: 2022 Puvula et al.Pyrethroids are extensively used insecticides by virtue of insecticidal activity potenti
Oncology January 02,2024
Role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies

Role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies

by Impact Journals LLCThe effect of pyrethroid derivatives on induction of autophagy. Credit: 2022 Puvula et al.Pyrethroids are extensively used insecticides by virtue of insecticidal activity potenti
Oncology January 02,2024
The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

by Justin Jackson , Medical XpressCohesin regulates alternative splicing. (A) Flowchart showing the experimental protocol, as detailed in Materials and Methods. (B) Schematic showing five different cl
Oncology January 02,2024
The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

by Justin Jackson , Medical XpressCohesin regulates alternative splicing. (A) Flowchart showing the experimental protocol, as detailed in Materials and Methods. (B) Schematic showing five different cl
Oncology January 02,2024
Brain tumor clinical trial: Failed Alzheimer's drug that boosts effect of radiotherapy to be tested in humans this year

Brain tumor clinical trial: Failed Alzheimer's drug that boosts effect of radiotherapy to be tested in humans this year

by Worldwide Cancer ResearchFlow chart with the design of a clinical trial with azeliragon in combination with radiotherapy in patients with brain metastases from non-small-cell lung cancer, breast ca
Oncology January 02,2024
Brain tumor clinical trial: Failed Alzheimer's drug that boosts effect of radiotherapy to be tested in humans this year

Brain tumor clinical trial: Failed Alzheimer's drug that boosts effect of radiotherapy to be tested in humans this year

by Worldwide Cancer ResearchFlow chart with the design of a clinical trial with azeliragon in combination with radiotherapy in patients with brain metastases from non-small-cell lung cancer, breast ca
Oncology January 02,2024
Mechanism identified for drug resistance in glioblastoma brain tumors

Mechanism identified for drug resistance in glioblastoma brain tumors

by Sarah Avery,Duke UniversityPro-tumor immune programming in the glioma microenvironment is CaMKK2 dependent. a Schematic depicting scRNA-seq experimental design. n = 4 WT and CaMKK2 KO mice ha
Oncology January 02,2024
Mechanism identified for drug resistance in glioblastoma brain tumors

Mechanism identified for drug resistance in glioblastoma brain tumors

by Sarah Avery,Duke UniversityPro-tumor immune programming in the glioma microenvironment is CaMKK2 dependent. a Schematic depicting scRNA-seq experimental design. n = 4 WT and CaMKK2 KO mice ha
Oncology January 02,2024
Intraventricular immunovirotherapy: A translational step forward

Intraventricular immunovirotherapy: A translational step forward

by Impact JournalsPutative mechanisms of toxicity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28343A new research perspective titled "Intraventricular immunovirotherapy; a tran
Oncology January 02,2024
Intraventricular immunovirotherapy: A translational step forward

Intraventricular immunovirotherapy: A translational step forward

by Impact JournalsPutative mechanisms of toxicity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28343A new research perspective titled "Intraventricular immunovirotherapy; a tran
Oncology January 02,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com